Please assess the completion status of the following clinical trial:

Trial Title: Adapted Physical Activity for Breast Cancer HER2 Positive Patient

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: SUPPORTIVE_CARE
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Women \> 18 years old~* Patient with HER2 (Human Epidermal growth factor Receptor 2) positive breast cancer histologically proven, eligible for neoadjuvant chemotherapy and targeted therapy against HER-2~* Affiliation to the French social security scheme~* Patient who signed the participation consent before entering the trial~* Medical fitness certificate for sport~Exclusion Criteria:~* Diagnosis of a second malignancy in the past 5 years, with the exception of a basal cell skin cancer~* Metastatic cancer~* Karnofsky index ≤ 90%~* Men~* Pregnant women~* Significant psychiatric or neurological abnormality~* Patient deprived of liberty by a court or administrative~* Contraindication for physical activity~* Patient unable to complete questionnaires (language barrier)~* Participation in a clinical trial with the same objective

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Interventional (Type: EXPERIMENTAL): Home-Based Adapted Physical Activity intervention during neoadjuvant chemotherapy :~150 minutes per week of aerobic and muscle strengthening exercises during 18 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).